Acquires CHA Healthcare shares for 80.3B KRW
차바이오텍
085660
Signal Score
Historical Avg Return (5d)
+0.00%
Data Coverage
100%n=709
Risk-adjusted indicator based on 709 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEUTRAL
Key Numbers
- • Acquisition Amount: 80,316,932,834 KRW
- • Shares Acquired: 2,524,051 Shares
- • Post-Acquisition Ownership: 60.1%
- • Ratio to Total Equity: 7.96%
- • CHA Healthcare 2025 Revenue: 999,111M KRW
AI Analysis Summary
Chabiotech Co.,Ltd. decided to acquire 2,524,051 shares of its subsidiary, CHA Healthcare, for 80,316,932,834 KRW, representing 7.96% of its total equity. This increases Chabiotech's ownership in CHA Healthcare to 60.1%. The acquisition is to purchase convertible preferred shares from existing shareholders exercising put options. CHA Healthcare reported 999,111M KRW in revenue and a net loss of 69,179M KRW in 2025. The transaction is scheduled for September 10, 2026. This move consolidates ownership in a key subsidiary, but the financial impact is neutral given the existing subsidiary relationship and the subsidiary's recent losses.
How This Event Is Evaluated
M&A / Merger Evaluation
M&A events are evaluated by assessing deal size relative to company scale, strategic rationale, financing structure, and integration risk.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Deal size relative to market value
- Strategic fit and synergy potential
- Financing structure (cash, stock, debt)
- Regulatory and integration risk
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.